annb0t
Top 20
Melbourne, Victoria --News Direct-- Recce Pharmaceuticals Ltd
Recce Pharmaceuticals Ltd (ASX:RCE) CEO James Graham tells Proactiveâs Elisha Newell that the company has secured ethics approval to expand its Phase 1 and 2 UTI studies with lead product RECCE® 327.
The key approval will expand the number of recruits that can participate across world class trial facilities in New South Wales.
Graham says R327 will be administered in around 16 participants as a broad-spectrum anti-infective...
>>> Read more: Recce Pharmaceuticals lands ethics approval for expanded UTI studies
Recce Pharmaceuticals Ltd (ASX:RCE) CEO James Graham tells Proactiveâs Elisha Newell that the company has secured ethics approval to expand its Phase 1 and 2 UTI studies with lead product RECCE® 327.
The key approval will expand the number of recruits that can participate across world class trial facilities in New South Wales.
Graham says R327 will be administered in around 16 participants as a broad-spectrum anti-infective...
>>> Read more: Recce Pharmaceuticals lands ethics approval for expanded UTI studies
